QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
QQQ   430.00 (-0.25%)
AAPL   173.19 (+0.29%)
MSFT   414.60 (+0.23%)
META   501.59 (+0.27%)
GOOGL   155.02 (+0.10%)
AMZN   183.40 (-0.12%)
TSLA   154.50 (-4.32%)
NVDA   869.08 (+1.05%)
AMD   163.17 (+1.78%)
NIO   3.75 (-3.60%)
BABA   69.67 (-1.35%)
T   16.07 (-1.05%)
F   11.99 (-1.96%)
MU   119.20 (-1.79%)
GE   153.95 (+0.16%)
CGC   6.69 (-4.15%)
DIS   112.79 (-0.14%)
AMC   2.48 (+0.40%)
PFE   25.87 (-0.15%)
PYPL   62.96 (-0.87%)
XOM   119.16 (-0.43%)
Free Trial

Vistagen Therapeutics (VTGN) Insider Trading & Ownership

→ Forget Nvidia, buy this A.I. Stock Now (From InvestorPlace) (Ad)
Free VTGN Stock Alerts
$4.62
-0.13 (-2.74%)
(As of 09:50 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Vistagen Therapeutics (NASDAQ:VTGN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.16%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$17.96 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get VTGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vistagen Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VTGN Insider Buying and Selling by Quarter

Ad InvestorPlace
REVEALED: Elon Musk’s Secret A.I. Facility?
I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.
Click here to see the details because there’s a lot of money at stake.

Vistagen Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/7/2023Commodore Capital LpMajor ShareholderBuy775,756$23.15$17,958,751.40  
(Data available from 1/1/2013 forward)

VTGN Insider Trading Activity - Frequently Asked Questions

Who is on Vistagen Therapeutics's Insider Roster?

The list of insiders at Vistagen Therapeutics includes Commodore Capital Lp, H. Ralph Snodgrass, Jerrold Duane Dotson, Jerry B Gin, Reid G Adler, Shawn Singh, and Venrock Healthcare Capital Par. Learn more on insiders at VTGN.

What percentage of Vistagen Therapeutics stock is owned by insiders?

3.16% of Vistagen Therapeutics stock is owned by insiders. Learn more on VTGN's insider holdings.

Which Vistagen Therapeutics insiders have been buying company stock?

The following insiders have purchased VTGN shares in the last 24 months: Commodore Capital Lp ($17,958,751.40), Jerry B Gin ($17,998.20), Reid G Adler ($51,000.00), and Shawn Singh ($102,000.00).

How much insider buying is happening at Vistagen Therapeutics?

Insiders have purchased a total of 809,089 VTGN shares in the last 24 months for a total of $18,129,749.60 bought.

Which Vistagen Therapeutics insiders have been selling company stock?

The following insider sold VTGN shares in the last 24 months: Venrock Healthcare Capital Par ($53,400.00).

How much insider selling is happening at Vistagen Therapeutics?

Insiders have sold a total of 2,000 Vistagen Therapeutics shares in the last 24 months for a total of $53,400.00 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:VTGN) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
He Is Giving Away Bitcoin
Crypto Swap Profits
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
The #1 Crypto for 2024
InvestorPlace
How to Know Which AI Company to Invest In… and When
Banyan Hill Publishing